scholarly journals Effect of first trimester maternal serum pregnancy associated plasma protein: a level on fetomaternal outcome

2019 ◽  
Vol 9 (1) ◽  
pp. 87
Author(s):  
Shilpi Singh ◽  
Pushpa Singh
Keyword(s):  
Pregnant Women ◽  
Plasma Protein ◽  
Protein A ◽  
First Trimester ◽  
Fetal Outcome ◽  
Maternal Serum ◽  
Maternal Outcome ◽  
Adverse Outcomes ◽  
High Risk Factors ◽  
Study Population

Background: Serum pregnancy-associated plasma protein-A (PAPP-A) levels fluctuate in continuation with the pregnancy and thus become an important standalone marker in monitoring the adverse outcomes that may occur in pregnancy.Methods: A prospective observational study was conducted in the department of obstetrics and gynaecology. A total of 240 pregnant women in their first trimester were included in the study. Serum PAPP-A levels were measured at 11-13+6week of gestation and were evaluated with respect to the feto-maternal outcome. The data was entered in MS excel spreadsheet and analysis was done using Statistical Package for Social Sciences (SPSS) version 21.0.Results: The mean age of the study population was 27 years. Among the maternal pregnancy parameters, PIH, pre-term labor and Emergency LSCS were significantly associated with low (<0.5 MoM) Serum PAPP-A levels, P<0.05. All the fetal outcome measures: IUGR, IUD, low birth weight, SGA babies, prematurity and NICU admissions, were significantly associated with low (<0.5 MoM) Serum PAPP-A levels, p <0.05.Conclusions: Serum PAPP-A in the early pregnancy showed significant correlation with feto-maternal outcome. Thus, it has the potential to be used as a prognostic factor and in the management of adverse outcomes by increasing surveillance for pregnant women with high-risk factors.

Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications

2013 ◽  
Vol 33 (9) ◽  
pp. 839-847 ◽  
Author(s):  
Francesco D'Antonio ◽  
Claudia Rijo ◽  
Basky Thilaganathan ◽  
Ranjit Akolekar ◽  
Asma Khalil ◽  
...  
Keyword(s):  
Plasma Protein ◽  
Protein A ◽  
First Trimester ◽  
Maternal Serum ◽  
Obstetric Complications

scholarly journals Maternal serum selenium as a predictor of preeclampsia

2018 ◽  
Vol 7 (11) ◽  
pp. 4628
Author(s):  
Vismaya Kaveri ◽  
Manjula S. K. ◽  
Sheela C. N. ◽  
Anura Kurpad ◽  
Pratibha Dwarkanath
Keyword(s):  
Blood Pressure ◽  
Pregnant Women ◽  
Venous Blood ◽  
First Trimester ◽  
Maternal Serum ◽  
Adverse Outcomes ◽  
Serum Selenium ◽  
College Hospital ◽  
National High Blood Pressure ◽  
Serum Selenium Levels

Background: Preeclampsia (PE) is a hypertension disorder condition occurring in 7-10% of all pregnancies. Preeclampsia if unidentified and left untreated is associated with poor maternal and fetal adverse outcomes. The objective of the present study was to characterize maternal serum selenium levels as a predictor of preeclampsia and to correlate dietary selenium intake with serum selenium levels in first trimester of pregnancyMethods: A retrospective case-control study of 107 pregnant women was conducted over 1.5 years at St. John’s Medical College Hospital. On screening for inclusion criteria, at baseline, information on maternal socio-demography, anthropometry, dietary intake and clinical examination was collected. A venous blood sample at baseline and 2nd or 3rdtrimester of pregnancy was collected for estimation of selenium concentrations. Blood pressure was measured at baseline and followed up during pregnancy to select cases and controls. Pregnant women were termed ‘cases’ based on NHBPEP (National High Blood Pressure Education Program) classification and subsequent 22 women with normal blood pressure controlled for age were termed as ‘controls.Results: No statistically significant differences were observed for baseline characteristics, biochemical parameters and blood pressure at recruitment among cases and controls. Cases had significant lower levels of energy (P=0.032) and micronutrients like zinc (P=0.027), selenium (P=0.022), magnesium (P=0.047) at first trimester. The serum selenium levels were significantly higher in cases as compared to the controls (69.2±13.7 vs. 59.6±12.9; P=0.021) at baseline.Conclusions: Our findings suggest that serum selenium levels may not be an independent predictor of preeclampsia. Assessment of other micronutrients, oxidative stress markers and other complementary elements may be useful in predicting preeclampsia.

scholarly journals First Trimester Biochemical Screening for Trisomy 21: The Role of Free Beta hCG, Alpha Fetoprotein and Pregnancy Associated Plasma Protein A

1994 ◽  
Vol 31 (5) ◽  
pp. 447-454 ◽  
Author(s):  
K Spencer ◽  
D A Aitken ◽  
J A Crossley ◽  
G McCaw ◽  
E Berry ◽  
...  
Keyword(s):  
Chorionic Gonadotropin ◽  
Plasma Protein ◽  
Human Chorionic Gonadotropin ◽  
Trisomy 21 ◽  
False Positive Rate ◽  
Protein A ◽  
First Trimester ◽  
Serum Markers ◽  
Maternal Serum ◽  
Detection Rates

The potential efficacy of screening for trisomy 21 in the first trimester, using maternal serum markers α fetoprotein, free β human chorionic gonadotropin, unconjugated oestriol and pregnancy associated plasma protein A, was studied in an unselected population of women between the seventh and fourteenth week of gestation. Using a combination of α fetoprotein and free β human chorionic gonadotropin, 53% of affected pregnancies could be identified at a false positive rate of 5%. Unconjugated oestriol and pregnancy associated plasma protein A levels were lower in cases of trisomy 21, but their inclusion with other markers did not significantly improve detection rate. Monitoring the same pregnancies also in the second trimester showed that screening in the first trimester identified the same cases as in the second. We conclude that first trimester screening using free β human chorionic gonadotropin and α fetoprotein, is a viable possibility and will lead to detection rates in excess of 50%. Prospective studies are needed to confirm these observations.

scholarly journals Does first‐trimester serum pregnancy‐associated plasma protein A differ in pregnant women with sickle cell disease?

2019 ◽  
Vol 39 (10) ◽  
pp. 921-924
Author(s):  
Gergana Peeva ◽  
Laura Oakley ◽  
Inez Rège ◽  
Kypros Nicolaides ◽  
Eugene Oteng‐Ntim
Keyword(s):  
Sickle Cell Disease ◽  
Pregnant Women ◽  
Sickle Cell ◽  
Plasma Protein ◽  
Protein A ◽  
First Trimester ◽  
Cell Disease
Sign in / Sign up

Export Citation Format

Share Document